Mpox (monkeypox) vaccine safety surveillance Our work Main navigation National vaccine safety surveillance Active vaccine safety surveillance Mpox (monkeypox) vaccine safety surveillance COVID-19 vaccine safety surveillance Adverse event of special interest (AESI) long-term follow-up program Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) Vaccine safety in Australia AusVaxSafety summary report Publications AusVaxSafety is actively monitoring adverse events following mpox (monkeypox) vaccination to ensure continuing safety of vaccines used. How to get involved? If you are getting a mpox vaccine, look out for the AusVaxSafety QR code registration poster at your immunisation clinic. Scan the QR code and complete the registration form to participate in the AusVaxSafety mpox vaccine surveillance program. How does it work? Following your mpox vaccination, AusVaxSafety will send you three short vaccine safety surveys - on day 7, day 14 and day 42 - giving you the opportunity to report any adverse events you may have experienced and if you had to seek medical care as a result. Depending on your survey responses, your state/territory health department or immunisation provider may contact you to collect more details. What happens to the information you provide? Your responses will contribute to the national mpox vaccine safety surveillance that AusVaxSafety is conducting as part of Australia's comprehensive vaccine safety monitoring. What about your personal data? AusVaxSafety only receives responses that are de-identified to protect your privacy. This means any information that could identify you will be removed. More information If you have any questions or would like more information on the AusVaxSafety mpox vaccine safety surveillance program, contact the AusVaxSafety team. View the latest AusVaxSafety mpox vaccine safety data here Our work Main navigation National vaccine safety surveillance Active vaccine safety surveillance Mpox (monkeypox) vaccine safety surveillance COVID-19 vaccine safety surveillance Adverse event of special interest (AESI) long-term follow-up program Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) Vaccine safety in Australia AusVaxSafety summary report Publications News & events All news & events 31 January 2023 | News Short-term adverse event profile of COVID-19 mRNA vaccines in Aussie kids: reassuring data from AusVaxSafety 22 December 2022 | News How common are severe side effects from COVID vaccines? And how are they detected? 12 December 2022 | News AusVaxSafety wins Research Australia Data Innovation Award 27 October 2022 | News JYNNEOS mpox (monkeypox) vaccination – dose 2 better tolerated than dose 1